MedTrace Logo

Optimisation of Exercise Intensity During High-Intensity Interval Training for Glucose Control in Prediabetes

NCT04256005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2022-02-22

No results posted yet for this study

Summary

The aim of the current study is to identify the optimal exercise intensity of the high-intensity phase during a bout of High-Intensity Interval Training (HIIT) to increase glucose clearance in a prediabetic population.

The study is a within-subjects randomised crossover design with participants attending the laboratory on seven occasions over a two week period. The first visit will be to perform medical screening and to obtain informed consent. The second visit will be to collect baseline measures, select meal plans, to collect an activity tracker and to complete a ramped exercise test to establish exercise intensity thresholds. The third visit will be to fit an interstitial glucose sensor and to collect the standardised meals which will be provided to each participant. Visits four, five, and six will be the experimental trials. The seventh visit will be to remove the interstitial glucose sensor and return the activity tracker.

Conditions

Interventions

OTHER

Exercise

Participants will complete one of two exercise conditions (50% Delta GET or 105% VO2peak).

Sponsors & Collaborators

  • Hywel Dda Health Board

    collaborator OTHER

  • Aberystwyth University

    lead OTHER

Principal Investigators

  • Cerin L Brain, BSc · Aberystwyth University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-11-25
Completion
2021-12-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04256005 on ClinicalTrials.gov